BIOMAT Database Logo BIOMAT Database Logo

Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation. 1996

P A Carpenter, and J B Ziegler, and M R Vowels
Department of Immunology, Prince of Wales Children's Hospital and School of Paediatrics, Sydney, Australia.

A 5-year-old boy with spastic quadriplegia, T cell immunodeficiency, hypouricemia and immune cytopenias from age 8 months, was found to have purine nucleoside phosphorylase (PNP) deficiency, and developed chronic lung disease. Successful matched sibling BMT for PNP deficiency has not previously been reported. BMT using marrow from an HLA-identical sibling donor was performed after conditioning with busulfan (16 mg/kg), cyclophosphamide (200 mg/kg), melphalan (90 mg/m2) and anti-thymocyte globulin (36 mg/kg). T lymphocyte numbers, PNP activity and uric acid levels rapidly improved and he remains well 12 months after transplant.

UI MeSH Term Description Entries
D008297 Male Males
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

P A Carpenter, and J B Ziegler, and M R Vowels
Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling.
March 1996, The Journal of pediatrics,
P A Carpenter, and J B Ziegler, and M R Vowels
Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency.
January 2002, Journal of pediatric hematology/oncology,
P A Carpenter, and J B Ziegler, and M R Vowels
An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication.
June 2008, Pediatric transplantation,
P A Carpenter, and J B Ziegler, and M R Vowels
[Purine nucleoside phosphorylase deficiency].
January 2000, Ryoikibetsu shokogun shirizu,
P A Carpenter, and J B Ziegler, and M R Vowels
Purine nucleoside phosphorylase deficiency.
January 1991, Immunodeficiency reviews,
P A Carpenter, and J B Ziegler, and M R Vowels
Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology.
March 2004, Pediatric research,
P A Carpenter, and J B Ziegler, and M R Vowels
[Purine nucleoside phosphorylase (PNP) deficiency].
January 1998, Ryoikibetsu shokogun shirizu,
P A Carpenter, and J B Ziegler, and M R Vowels
[PNP (purine nucleoside phosphorylase) deficiency].
January 2003, Nihon rinsho. Japanese journal of clinical medicine,
P A Carpenter, and J B Ziegler, and M R Vowels
[Purine nucleoside phosphorylase (PNP) deficiency].
December 1996, Nihon rinsho. Japanese journal of clinical medicine,
P A Carpenter, and J B Ziegler, and M R Vowels
Stroke in purine nucleoside phosphorylase deficiency.
February 1995, Pediatric neurology,
Copied contents to your clipboard!